-
Faricimab, sold
under the
brand name Vabysmo, is a
monoclonal antibody used for the
treatment of
neovascular age-related
macular degeneration (nAMD) and...
- Drusen, is in preparation. Ranibizumab, aflibercept, brolucizumab, and
faricimab are
approved VEGF
inhibitors for the
treatment of CNV in wet AMD. All...
-
mouse CD15
appendicitis (diagnosis)
Faralimomab mab
mouse IFN
receptor Faricimab Vabysmo mab
humanized VEGF-A and Ang-2 Y angiogenesis,
ocular vascular...
- S01LA06
Brolucizumab S01LA07 Abi****r
pegol S01LA08
Bevacizumab S01LA09
Faricimab S01XA01
Guaiazulene S01XA02
Retinol S01XA03
Sodium chloride, hypertonic...
-
approved by the US FDA: blinatumomab, emacizumab, amivantamab, tebentafusp,
faricimab, teclistamab, mosunetuzumab, epcoritamab, glofitamab.
Among the bsAb programs...
